Grifols, with more than 24,000 employees in 30 countries and regions, is committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry.
Grifols leads in changing perceptions about plasma donation. We speak out about the pride we have in our donors and the vital importance of our products for patients and their families.
Every donor must be screened for HIV, hepatitis B and hepititis C at each donation using nucleic amplifiedtesting (NAT), a statte-of-the-art method that tests for DNA particles of viruses. Each donation is tested using a Serological test that looks for antibodies that body produces in response to a virus. These Screening tests are performed at Grifols Laboratories and are not formal medical Diagnosis tests
If you are interested in this item and have some questions, feel free send an inquiry.
Click Here
On the Go?
Scan our QR code and use your phone to access our catalog.Text GRIFOLSCEDAR to 866-866-5545